Faeth Therapeutics Inc. Company Profile
NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Faeth Therapeutics at a glance
Faeth Therapeutics Inc. (NASDAQ: FTH) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Rockville, MD. Faeth Therapeutics is led by Mr. Anand Parikh Esq., J.D. and employs about 29 people. The company's shares have traded publicly since 2021.
At a market capitalization of $203.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001829802, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Faeth Therapeutics do?
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.
Business description based on the company's public filings.
Company information
- Legal name
- Faeth Therapeutics Inc.
- Ticker
- NASDAQ: FTH
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Anand Parikh Esq., J.D.
- Employees
- 29
- Headquarters
- 1405 Research Boulevard, Rockville, MD, United States
- Phone
- 240 243 8000
- Website
- faeththerapeutics.com
- IPO year
- 2021
- Market cap
- $203.65M
- SEC CIK
- 0001829802
- Latest annual report
- 10-K/A · Jun 2, 2026
Companies similar to Faeth Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BCYCBicycle Therapeutics plc ADR | 2.90 | -4.92% | $203.27M | vs FTH |
| DRUGBright Minds Biosciences Inc. | 20.40 | -1.45% | $201.23M | vs FTH |
| VNDAVanda Pharmaceuticals Inc. | 3.45 | -6.13% | $208.32M | vs FTH |
| NGENNervGen Pharma Corp. | 1.85 | -3.91% | $198.55M | vs FTH |
| CYPHCypherpunk Technologies Inc. | 1.41 | -18.02% | $210.15M | vs FTH |
| BIOABioAge Labs Inc. | 4.28 | -9.13% | $196.67M | vs FTH |
| YARWYarrow Bioscience Inc. | 12.90 | -9.35% | $196.53M | vs FTH |
| ACIUAC Immune SA | 1.95 | -8.45% | $193.88M | vs FTH |